Preclinical studies have shown that several small-molecule inhibitors of HO-1 can reduce tumor growth, enhance the efficacy of chemotherapeutic agents, and induce apoptosis in cancer cells [31,33]. The gene discussed is HMOX1; the disease is neoplasm.